Sponsored by:

ACC/AHA Release Recommendations For Congenital and Genetic Heart Disease Screenings in Youth SECURITY: Six Month vs. 12 Month DAT Following DES Implantation ISAR TRIPLE ACC Legislative Conference 2014 ABSORB II: Everolimus Eluting Bioresorbable Scaffold vs Everolimus Full Coverage of TCT 2014

Featured Videos

Advertisement
Advertisement